Education
About Us
Working with TipRanks
Follow Us
Thermo Fisher (TMO)
NYSE:TMO
TMO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$409.85 - $627.88
Previous CloseN/A
Volume471.20K
Average Volume (3M)2.22M
Market Cap
$169.62B
Enterprise Value$226.53B
Total Cash (Recent Filing)$4.13B
Total Debt (Recent Filing)$34.19B
Price to Earnings (P/E)27.2
Beta0.79
Next Earnings
Apr 23, 2025EPS Estimate
5.1Last Dividend Ex-Date
Mar 14, 2025Dividend Yield0.38%
Share Statistics
EPS (TTM)6.10
Shares Outstanding377,492,280
10 Day Avg. Volume3,263,600
30 Day Avg. Volume2,216,204
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.56
Price to Cash Flow (P/CF)14.80
P/FCF Ratio14.80
Enterprise Value/Market Cap1.34
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit12.51
Enterprise Value/Ebitda21.37
Forecast
1Y Price Target
$562.95Price Target Upside32.70% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering19
---
Bulls Say, Bears Say
Bulls Say
Investment In FacilitiesTo support long-term growth and expand market share, TMO announced plans to invest US$2bn over the next four years in expanding its US manufacturing and R&D facilities, in response to growing customer demand.
Revenue GrowthManagement maintained its full-year revenue guidance, projecting revenue growth of 1.0% to 3.1% for 2025.
Shareholder OpportunitiesThermo Fisher Scientific shares are at historical 5-year lows, presenting a potential attractive opportunity for investors.
Bears Say
Export ChallengesManagement guided to a $400M revenue hit due to reduced U.S exports (demand destruction), which, net of mitigation efforts and higher-cost China imports, should impact adjusted operating profit by $375M.
Revenue HeadwindsThermo Fisher Scientific is facing a $400 million top-line headwind from US-to-China sales and a $500 million headwind related to US policy changes.
Tariffs And Policy ImpactThe company revised its adjusted EPS guidance downward, expecting a range from a 0.6% decline to 4.4% growth, mainly due to the impact of tariffs.
---
Ownership Overview
0.12% Insiders
24.26% Mutual Funds
0.85% Other Institutional Investors
55.20% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TMO FAQ
What was Thermo Fisher’s price range in the past 12 months?
Thermo Fisher lowest stock price was $409.85 and its highest was $627.88 in the past 12 months.
What is Thermo Fisher’s market cap?
Thermo Fisher’s market cap is $169.62B.
When is Thermo Fisher’s upcoming earnings report date?
Thermo Fisher’s upcoming earnings report date is Apr 23, 2025 which is 4 days ago.
How were Thermo Fisher’s earnings last quarter?
Thermo Fisher released its earnings results on Apr 23, 2025. The company reported $5.15 earnings per share for the quarter, beating the consensus estimate of $5.101 by $0.049.
Is Thermo Fisher overvalued?
According to Wall Street analysts Thermo Fisher’s price is currently Undervalued.
Does Thermo Fisher pay dividends?
Thermo Fisher pays a Quarterly dividend of $0.43 which represents an annual dividend yield of 0.38%. See more information on Thermo Fisher dividends here
What is Thermo Fisher’s EPS estimate?
Thermo Fisher’s EPS estimate is 5.1.
How many shares outstanding does Thermo Fisher have?
Thermo Fisher has 377,492,280 shares outstanding.
What happened to Thermo Fisher’s price movement after its last earnings report?
Thermo Fisher reported an EPS of $5.15 in its last earnings report, beating expectations of $5.101. Following the earnings report the stock price went down -0.711%.
Which hedge fund is a major shareholder of Thermo Fisher?
Currently, no hedge funds are holding shares in TMO
---
Thermo Fisher Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$562.95 (32.70% Upside)
$562.95 (32.70% Upside)
Blogger Sentiment
Bullish
TMO Sentiment 87%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 335.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.1%
Last 30 Days ▲ 1.6%
Last 30 Days ▲ 1.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.27%
12-Months-Change
Fundamentals
Return on Equity
13.75%
Trailing 12-Months
Asset Growth
-1.42%
Trailing 12-Months
Company Description
Thermo Fisher
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
---
TMO Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong financial performance and strategic initiatives in innovation and M&A. However, significant challenges were noted due to macroeconomic conditions, US-China tariffs, and pressures in the academic and government markets.Read More>---
TMO Revenue Breakdown
54.01% Laboratory Products and Biopharma Services
22.46% Life Sciences Solutions
17.40% Analytical Instruments
10.52% Specialty Diagnostics
---
TMO Stock 12 Month Forecast
Average Price Target
$562.95
▲(32.70% Upside)
Technical Analysis
Best Analysts Covering TMO
1 Year
1 Year Success Rate
26/42 ratings generated profit
1 Year Average Return
+11.56%
reiterated a buy rating 4 days ago
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 61.90% of your transactions generating a profit, with an average return of +11.56% per trade.
---